Results 231 to 240 of about 2,008,123 (283)

Risk of Moderate to Severe Ocular Surface Disease Associated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy: A Multicenter Cohort Study. [PDF]

Ophthalmol Ther
Tsao YT, Kang EY, Wu CE, Hung N, Chen HC, Hsiao CH.   +5 more
europepmc   +1 more source

Longitudinal pharmacogenomic analysis of refractory lung cancer to identify therapeutic candidates for epidermal growth factor receptor-tyrosine kinase inhibitor resistance subclones. [PDF]

Exp Mol Med
Yu N, Hwang M, Ahn BC, Lee Y, Hong S, Sim H, Song BR, Kim S, Park C, Han JY.   +9 more
europepmc   +1 more source

Efficacy of Pyrotinib combined with Trastuzumab in the treatment of patients with human epidermal growth factor receptor-2 positive breast cancer. [PDF]

Pak J Med Sci
Tang B, Yi X, Mo Q, Tang Y, Zhang L, Xie L.   +5 more
europepmc   +1 more source